Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

87.49
Delayed Data
As of Apr 20
 +1.21 / +1.40%
Today’s Change
29.46
Today|||52-Week Range
95.91
+49.10%
Year-to-Date

Today’s Trading

Previous close86.28
Today’s open85.93
Day’s range85.07 - 88.66
Volume101,916
Average volume (3 months)204,507
Market cap$1.6B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-19.47%
Earnings growth (this year)+3.02%
Earnings growth (next 5 years)--
Revenue growth (last year)+16.48%
P/E ratio49.7
Price/Sales8.83
Price/Book5.40

Competitors

 Today’s
change
Today’s
% change
KERXKeryx Biopharmaceuti...-0.08-1.65%
TGTXTG Therapeutics Inc-0.30-2.04%
PTCTPTC Therapeutics Inc+0.13+0.50%
ADROAduro Biotech Inc-0.15-2.11%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$102.8M
Annual profit (last year)$17.7M
Net profit margin17.23%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay R. Luly
CFO, Principal Accounting Officer &
SVP-Finance
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts